Scientists probe why men fare worse with deadly brain cancer
NCT ID NCT07472387
First seen Apr 03, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study looks at how male hormones (androgens) influence the immune cells around glioblastoma, the most aggressive brain cancer. Researchers will analyze tumor and blood samples from 40 men and women aged 18-55 with newly diagnosed glioblastoma. The goal is to understand why men get this cancer more often and have worse outcomes, which could lead to better treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neuro-oncology department, Pitié Salpêtrière hospital
Paris, 75013, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.